"I can walk out that door and know I am not going to fall," Starkweather said after receiving much needed home renovations.

Phase III Vivacity-MG3 trial shows that nipocalimab, an investigational FcRn blocker, significantly the improves symptoms of generalized myasthenia gravis with a manageable safety profile.

Flanked by billionaires, tech moguls, and global leaders on Monday, Trump used the occasion to sign a series of executive ...

The FDA has granted priority review to a Biologics License Application for nipocalimab to treat individuals with generalized ...

Every New Year’s Eve, the traditional song is sung as we raise a toast to bid goodbye to the old year and usher in the new. Even if you don’t know the ...

The ADL’s Global 100 survey found that of more than 58,000 adults questioned from 103 different countries, 46% of them displayed antisemitic attitudes, more than double the levels of the first ...

We’re not even 24 hours into the second Donald Trump term and already there’s a ‘New Nazis’ panic. Only this time it’s not ...

Elon Musk stirred controversy online after raising his hand in an odd salute that many are saying looks like a Nazi salute.

Posts blaming Israel for the fires are similar to the narratives that followed Hurricane Helene and Hurricane Milton in 2024 ...

It's important to understand who may qualify for long-term care insurance coverage if you're planning to buy a policy this ...

The application is supported by data from the randomized, double-blind, placebo-controlled phase 3 Vivacity-MG3 study.